Gland Pharma looking at complex injectables segment, manufacturing of biosimilars

08 Nov 2021 Evaluate

Gland Pharma is looking at complex injectables segment, contract development, and manufacturing of biosimilars to fuel near term growth. The company has made good progress in the R&D field for planned submission batches for complex injectables to be filed in the current financial year. The company is on track to make four complex injectable filings in this financial year. The company's near-term focus remains on establishing a strong portfolio of complex injectables. It is also looking at acquisition opportunities to help expedite the development process. Installation of new lines catering to suspensions and hormonal products has been completed.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in over 60 countries, including the US, Canada, Australia and India.

Gland Pharma Share Price

1681.95 -39.70 (-2.31%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×